Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019

por Andraka-Christou, Barbara, Golan, Olivia, Totaram, Rachel, Ohama, Maggie, Saloner, Brendan, Gordon, Adam J., Stein, Bradley D.
Publicado 2023

Key person-centered care domains for residential substance use disorder treatment facilities: former clients’ perspectives

por Andraka-Christou, Barbara, Atkins, Danielle N., Shields, Morgan C., Golan, Olivia K., Totaram, Rachel, Cortelyou, Kendall, Lambie, Glenn W., Mazurenko, Olena
Publicado 2023

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018

por Golan, Olivia K., Sheng, Flora, Dick, Andrew W., Sorbero, Mark, Whitaker, Daniel J., Andraka-Christou, Barbara, Pigott, Therese, Gordon, Adam J., Stein, Bradley D.
Publicado 2023

Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

por Stein, Bradley D., Saloner, Brendan K., Golan, Olivia K., Andraka-Christou, Barbara, Andrews, Christina M., Dick, Andrew W., Davis, Corey S., Sheng, Flora, Gordon, Adam J.
Publicado 2023